Safe Hold Parameters for Scheduled Lispro with Meals
Hold prandial insulin lispro if the patient is not able to eat. 1
Primary Hold Parameter: Meal Consumption Status
The Endocrine Society Clinical Practice Guideline provides the most direct guidance on this question. The fundamental hold parameter is whether the patient can eat—not a specific glucose threshold. The guideline explicitly states: "Give rapid-acting (prandial) insulin in three equally divided doses before each meal. Hold prandial insulin if patient is not able to eat." 1
This recommendation is consistent across multiple sections of the same guideline 1, emphasizing that the ability to consume the meal is the primary determinant for administering scheduled mealtime lispro.
Glucose-Based Hold Considerations
While meal consumption is the primary hold parameter, glucose levels should trigger reassessment of the insulin regimen:
- Reassess antidiabetic therapy when blood glucose falls below 100 mg/dL (5.6 mmol/L)
- Modification of glucose-lowering treatment is usually necessary when blood glucose is below 70 mg/dL (3.9 mmol/L) 1
These thresholds are for reassessing the overall insulin regimen rather than serving as absolute hold parameters for individual doses. However, in practical clinical medicine, holding or reducing the scheduled lispro dose is prudent when pre-meal glucose is <70 mg/dL, particularly in elderly patients, those with impaired renal function (GFR <60 mL/min), or insulin-sensitive patients. 1
Timing Considerations for Meal Delays
If a meal is delayed, do not give the scheduled lispro dose at the originally planned time. The pharmacodynamics of lispro show:
- Time to first measurable effect: ~15-17 minutes 2
- Time to peak effect: ~120-174 minutes depending on dose 2
- Duration of effect: ~4.6-7.3 hours 2
Given this rapid onset, administering lispro without subsequent food intake within 15-20 minutes creates significant hypoglycemia risk. Lispro should be administered 0-2 minutes before the meal 2, or in some cases up to 20 minutes after meal initiation if needed 3.
Special Populations Requiring Lower Thresholds
Use the insulin-sensitive correction scale column (which implies more conservative dosing) for:
- Patients who are not eating
- Elderly patients (≥70 years)
- Those with impaired renal function (GFR <60 mL/min) 1
For these populations, consider holding scheduled lispro even at higher glucose levels (e.g., <100 mg/dL) if there is uncertainty about meal consumption.
Common Pitfalls to Avoid
Do not rely on sliding scale insulin alone—the guideline explicitly recommends against prolonged use of SSI as the sole method for glycemic control 1
Do not give lispro "just in case" the patient might eat—the rapid onset means hypoglycemia will occur before corrective action can be taken
Do not use morning fasting glucose as the sole guide for basal insulin adjustment—this can lead to excessive basal insulin and daytime hypoglycemia, which then necessitates holding prandial doses 4
For NPO patients: Continue basal insulin but hold all prandial insulin; use correction doses of rapid-acting insulin every 4-6 hours only if needed 1
Practical Algorithm
Before each scheduled lispro dose:
Can the patient eat the meal within the next 15 minutes?
- No → HOLD the dose
- Yes → Proceed to step 2
Is pre-meal glucose <70 mg/dL?
- Yes → HOLD or reduce the dose (especially in elderly, renal impairment, or insulin-sensitive patients)
- No → Proceed to step 3
Is pre-meal glucose 70-100 mg/dL in a high-risk patient (elderly, renal impairment, insulin-sensitive)?
- Yes → Consider reducing the dose by 50% or using correction insulin only
- No → Give scheduled dose as ordered
Administer lispro 0-2 minutes before meal consumption 2
This approach prioritizes prevention of hypoglycemia (the most immediate threat to morbidity and mortality) while maintaining glycemic control.